Northern Trust’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145M | Buy |
4,021,850
+1,045,593
| +35% | +$37.7M | 0.02% | 577 |
|
|
2025
Q1 | $92.7M | Sell |
2,976,257
-354,172
| -11% | -$11M | 0.01% | 742 |
|
|
2024
Q4 | $85M | Buy |
3,330,429
+376,619
| +13% | +$9.61M | 0.01% | 801 |
|
|
2024
Q3 | $83.6M | Sell |
2,953,810
-343,467
| -10% | -$9.72M | 0.01% | 732 |
|
|
2024
Q2 | $86.9M | Buy |
3,297,277
+484,144
| +17% | +$12.8M | 0.01% | 696 |
|
|
2024
Q1 | $85.4M | Buy |
2,813,133
+178,958
| +7% | +$5.43M | 0.01% | 689 |
|
|
2023
Q4 | $74M | Buy |
2,634,175
+36,226
| +1% | +$1.02M | 0.01% | 760 |
|
|
2023
Q3 | $70.5M | Buy |
2,597,949
+224,261
| +9% | +$6.09M | 0.01% | 740 |
|
|
2023
Q2 | $73M | Sell |
2,373,688
-104,040
| -4% | -$3.2M | 0.01% | 723 |
|
|
2023
Q1 | $89.3M | Buy |
2,477,728
+48,275
| +2% | +$1.74M | 0.02% | 642 |
|
|
2022
Q4 | $96M | Buy |
2,429,453
+78,769
| +3% | +$3.11M | 0.02% | 596 |
|
|
2022
Q3 | $94.5M | Sell |
2,350,684
-32,350
| -1% | -$1.3M | 0.02% | 563 |
|
|
2022
Q2 | $100M | Sell |
2,383,034
-25,650
| -1% | -$1.08M | 0.02% | 562 |
|
|
2022
Q1 | $93.8M | Buy |
2,408,684
+147,062
| +7% | +$5.73M | 0.02% | 668 |
|
|
2021
Q4 | $90.1M | Buy |
2,261,622
+592,948
| +36% | +$23.6M | 0.01% | 713 |
|
|
2021
Q3 | $60.3M | Buy |
1,668,674
+450,183
| +37% | +$16.3M | 0.01% | 946 |
|
|
2021
Q2 | $49.9M | Sell |
1,218,491
-87,142
| -7% | -$3.57M | 0.01% | 1139 |
|
|
2021
Q1 | $57M | Buy |
1,305,633
+558,274
| +75% | +$24.4M | 0.01% | 1017 |
|
|
2020
Q4 | $37.4M | Buy |
747,359
+197,318
| +36% | +$9.88M | 0.01% | 1320 |
|
|
2020
Q3 | $23.1M | Buy |
550,041
+391,165
| +246% | +$16.5M | 0.01% | 1514 |
|
|
2020
Q2 | $7.71M | Buy |
+158,876
| New | +$7.71M | ﹤0.01% | 2264 |
|